GWMR
PTCT icon

GC Wealth Management RIA’s PTC Therapeutics PTCT Stock Holding History

GC Wealth Management RIA’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,196
Closed -$316K – 532
2025
Q1 		$316K Sell
6,196
-1,836
-23% -$91.6K 0.06% 243
2024
Q4 		$363K Buy
+8,032
New +$344K 0.06% 216

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GC Wealth Management RIA's PTCT Position: Q2 2025 in Review

GC Wealth Management RIA sold out of PTC Therapeutics (PTCT) in Q2 2025, closing a stake of 6,196 shares — an estimated $316K sold.

GC Wealth Management RIA first reported a position in PTCT in Q4 2024 and held it in 2 quarters. The position peaked at $363K in Q4 2024. 283 funds tracked by Wall St. Rank hold PTCT as of Q2 2025.

  • GC Wealth Management RIA reported no remaining PTC Therapeutics position as of Q2 2025 after selling out during the quarter.
  • GC Wealth Management RIA sold 6,196 PTC Therapeutics shares in Q2 2025, an estimated $316K.
  • GC Wealth Management RIA first reported a position in PTC Therapeutics in Q4 2024 and held it in 2 quarters.
  • GC Wealth Management RIA's PTC Therapeutics position peaked at $363K in Q4 2024.
  • 283 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2025.

Based on GC Wealth Management RIA's 13F filing for Q2 2025, filed 17 Jul 2025.